Con gran impacto artículo sobre vacuna cubana contra la hepatitis B
La Habana, 25 jun.- La revista científica Vaccines destacó el gran impacto a nivel internacional de un artículo sobre la
Read MoreLa Habana, 25 jun.- La revista científica Vaccines destacó el gran impacto a nivel internacional de un artículo sobre la
Read MoreHavana, Apr 14.- The Cuban scientists who work in the fight against Covid-19 have devised new clinical trials and other actions that are being currently assessed to improve the vaccination strategy.
Read MoreHavana, Apr 12.- The Lancet Discovery Science, from the United Kingdom, published a scientific article on Cuba’s Abdala vaccine against Covid-19, describing it as safe, well-tolerated and an inducer of a powerful immune response against the SARS-CoV-2 coronavirus.
Read MoreHavana, Apr 6.- President Miguel Díaz-Canel described as unstoppable the impact of Cuba’s homegrown vaccines against Covid-19, and noted the fact that one of them, Abdala, has a dossier ready to be certified internationally.
Read MoreHavana, March 29.- The president of Cuba, Miguel Díaz-Canel, spoke here with the director general of the World Intellectual Property Organization (WIPO), Daren Tang.
Read MoreHavana, Mar 19.- A total of 9,899,478 people, 89.4 percent of Cuba’s population, have been fully vaccinated against Covid-19, the Ministry of Public Health (MINSAP) reported.
Read MoreHavana, Feb 9.- Cuba reports 10,581,126 people with at least one dose of a Covid-19 vaccine, a figure that places the country in the third place among the world in this indicator.
Read MoreHavana, Feb 6.- 88 percent of the population in Cuba, amounting to 9,839,682, completed the full Covid-19 vaccination schedule, the Ministry of Public Health (MINSAP) reported.
Read MoreHavana, Jan 26.- Cuba will present in the next few days the dossier of its anti-Covid-19 vaccines to the World Health Organization (WHO) for the certification of the immunogens, it was reported.
Read MoreHavana, Jan 24.- The first clinical studies of the application of Cuba’s first nasal vaccine candidate, named Mambisa, to patients convalescing from Covid-19 and as a booster are ongoing.
Read More